Rho Ventures Iv Lp - Net Worth and Insider Trading

Rho Ventures Iv Lp Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rho Ventures Iv Lp owns 4 companies in total, including IntraLinks Holdings Inc (IL) , Rocket Pharmaceuticals Inc (RCKT) , and Anacor Pharmaceuticals Inc (ANAC) among others .

Click here to see the complete history of Rho Ventures Iv Lp’s form 4 insider trades.

Insider Ownership Summary of Rho Ventures Iv Lp

Ticker	Comapny	Transaction Date	Type of Owner
IL	IntraLinks Holdings Inc	2017-01-19	10 percent owner
RCKT	Rocket Pharmaceuticals Inc	2015-02-17	10 percent owner
ANAC	Anacor Pharmaceuticals Inc	2014-02-03	10 percent owner
		2006-11-06	10 percent owner

Rho Ventures Iv Lp Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Rho Ventures Iv Lp Ownership Network

Ownership Network List of Rho Ventures Iv Lp

No Data

Ownership Network Relation of Rho Ventures Iv Lp

Rho Ventures Iv Lp Owned Company Details

What does IntraLinks Holdings Inc do?

Who are the key executives at IntraLinks Holdings Inc?

Rho Ventures Iv Lp is the 10 percent owner of IntraLinks Holdings Inc. Other key executives at IntraLinks Holdings Inc include 10 percent owner Ta Associates, L.p. , 10 percent owner Ta Atlantic & Pacific V L P , and 10 percent owner Ta Investors Ii L.p. .

IntraLinks Holdings Inc (IL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of IntraLinks Holdings Inc (IL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of IntraLinks Holdings Inc (IL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

IntraLinks Holdings Inc (IL)'s detailed insider trading history can be found in Insider Trading Tracker table.

IntraLinks Holdings Inc Insider Transactions

No Available Data

What does Rocket Pharmaceuticals Inc do?

Who are the key executives at Rocket Pharmaceuticals Inc?

Rho Ventures Iv Lp is the 10 percent owner of Rocket Pharmaceuticals Inc. Other key executives at Rocket Pharmaceuticals Inc include See Remarks John Militello , director & See Remarks David P Southwell , and Chief Medical Officer Mark Andrew White .

Rocket Pharmaceuticals Inc (RCKT) Insider Trades Summary

Over the past 18 months, Rho Ventures Iv Lp made no insider transaction in Rocket Pharmaceuticals Inc (RCKT). Other recent insider transactions involving Rocket Pharmaceuticals Inc (RCKT) include a net sale of 23,282 shares made by John Militello , a net sale of 41,355 shares made by Gaurav Shah , and a net sale of 308,989 shares made by Gotham Makker .

In summary, during the past 3 months, insiders sold 418,173 shares of Rocket Pharmaceuticals Inc (RCKT) in total and bought 0 shares, with a net sale of 418,173 shares. During the past 18 months, 486,057 shares of Rocket Pharmaceuticals Inc (RCKT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 486,057 shares.

Rocket Pharmaceuticals Inc (RCKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rocket Pharmaceuticals Inc Insider Transactions

No Available Data

What does Anacor Pharmaceuticals Inc do?

Who are the key executives at Anacor Pharmaceuticals Inc?

Rho Ventures Iv Lp is the 10 percent owner of Anacor Pharmaceuticals Inc. Other key executives at Anacor Pharmaceuticals Inc include Executive VP and CFO Graeme Bell , EVP and General Counsel Ryan T Sullivan , and director & President and CEO Paul L Berns .

Anacor Pharmaceuticals Inc (ANAC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Anacor Pharmaceuticals Inc (ANAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Anacor Pharmaceuticals Inc (ANAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Anacor Pharmaceuticals Inc (ANAC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Anacor Pharmaceuticals Inc Insider Transactions

No Available Data

What does Vanda Pharmaceuticals Inc do?

Who are the key executives at Vanda Pharmaceuticals Inc?

Rho Ventures Iv Lp is the 10 percent owner of Vanda Pharmaceuticals Inc. Other key executives at Vanda Pharmaceuticals Inc include director & Chief Executive Officer Mihael Hristos Polymeropoulos , SVP & General Counsel Timothy Williams , and SVP & Business Development Gunther Birznieks .

Vanda Pharmaceuticals Inc (VNDA) Insider Trades Summary

Over the past 18 months, Rho Ventures Iv Lp made no insider transaction in Vanda Pharmaceuticals Inc (VNDA). Other recent insider transactions involving Vanda Pharmaceuticals Inc (VNDA) include a net sale of 51,638 shares made by Kevin Patrick Moran , a net sale of 56,426 shares made by Timothy Williams , and a net sale of 196,036 shares made by Mihael Hristos Polymeropoulos .

In summary, during the past 3 months, insiders sold 121,098 shares of Vanda Pharmaceuticals Inc (VNDA) in total and bought 0 shares, with a net sale of 121,098 shares. During the past 18 months, 377,072 shares of Vanda Pharmaceuticals Inc (VNDA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 377,072 shares.

Vanda Pharmaceuticals Inc (VNDA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Vanda Pharmaceuticals Inc Insider Transactions

No Available Data

Rho Ventures Iv Lp Mailing Address

Above is the net worth, insider trading, and ownership report for Rho Ventures Iv Lp. You might contact Rho Ventures Iv Lp via mailing address: 124 Dune Road, Quogue Ny 11959.

Discussions on Rho Ventures Iv Lp

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.